Related Experiment Video
Updated: Dec 25, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Transcatheter Aortic Valve Replacement Outcomes Based on the Presence of Chronic Total Occlusion
Travis M Howard1, Eric P Cantey1, AbdulRahman A Abutaleb1
1Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Insights
Chronic total occlusion (CTO) before transcatheter aortic valve replacement (TAVR) did not affect survival or functional outcomes. However, CTO was associated with lower left ventricular ejection fraction post-TAVR.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Chronic total occlusion (CTO) is associated with poorer prognosis.
- Percutaneous coronary intervention (PCI) for CTO has shown benefits, but its role before transcatheter aortic valve replacement (TAVR) is unclear.
Purpose of the Study:
- To investigate the prognostic impact of pre-TAVR CTO on post-TAVR outcomes.
- To evaluate the association between CTO and mortality, functional status, and left ventricular (LV) function after TAVR.
Main Methods:
- Retrospective review of 783 consecutive TAVR cases.
- Analysis of pre-TAVR angiograms for CTO presence.
- One-year and long-term follow-up for mortality, functional status, and LV ejection fraction.
Main Results:
- 12.6% of patients had a pre-TAVR CTO.
- No significant association between CTO and one-year mortality, functional status, quality of life, or adverse events.
- No difference in long-term survival between CTO and non-CTO groups.
- LV ejection fraction was lower in the CTO group at baseline and one year.
Conclusions:
- Pre-TAVR CTO does not impact mortality or functional improvement after TAVR.
- CTO is associated with reduced LV ejection fraction both at baseline and one year post-TAVR.
- The findings suggest CTO is not a significant prognostic factor for TAVR outcomes in elderly, high-risk patients.
Aims:
Chronic total occlusion (CTO) has been linked to worse survival. While controversial and limited to observational data, successful CTO percutaneous coronary intervention (PCI) has been associated with improved left ventricular (LV) function and mortality. However, the role of CTO PCI prior to transcatheter aortic valve replacement (TAVR) is not clear. We sought to explore the prognostic impact of a pre-TAVR CTO on post-TAVR outcomes.
Methods And Results:
We retrospectively reviewed 783 consecutive TAVR cases performed at a single tertiary care medical center. Pre-TAVR angiograms were analyzed for the presence of a CTO. At the time of TAVR, 12.6% (n = 99) patients had a CTO. At one-year post-TAVR, there was no significant association between the presence of a CTO and death (14.2% vs 13.1%, p = 0.75), functional status, quality of life, or adverse events. There was also no difference in long-term survival (4.1 years vs 4.1 years, p = 0.55). LV ejection fraction was lower in the CTO group at baseline and one year (p < 0.01).
Conclusions:
The presence of a CTO did not have any prognostic impact on mortality, change in LV function, or improvement in functional status and angina scores following TAVR in our cohort of elderly, high-risk patients. CTO before TAVR was associated with decreased ejection fraction at baseline and at one year.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation III: Medical Management

